MINNEAPOLIS, November 10, 2017 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today that the GLUCOCARD® Shine XL, ARKRAY’s newest blood glucose monitoring system (BGMS), is now being shipped to customers in the United States.
“The availability of the GLUCOCARD Shine XL demonstrates ARKRAY’s commitment to provide affordable, easy-to-use blood glucose monitoring systems to people with diabetes,” said ARKRAY USA President Jonathan Chapman. “The GLUCOCARD Shine XL is the latest in the growing line of GLUCOCARD Shine family BGMS utilizing a single test strip platform.”
Highly accurate with a large LED screen intended to facilitate quick and easy viewing of blood glucose test results, the GLUCOCARD Shine XL BGMS offers an ergonomically designed meter that provides a secure grip during testing. The GLUCOCARD Shine XL uses the same test strips as the previously launched GLUCOCARD Shine, which has also been proven to provide highly accurate test results in an easy to use form factor.1
About ARKRAY USA, Inc.
ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition. ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit www.arkrayusa.com.
1) ARKRAY Clinical Compendium on Blood Glucose Monitoring Systems, 2014-2016